Fleury SA operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fleury SA with three other
pharmaceutical manufacturers in Latin America:
Diagnosticos Da America SA
sales of 2.79 billion Brazilian Reals [US$881.52 million]
of which 100%
was servi os auxiliares),
Genomma Lab Internacional Sab De Cv
(11.04 billion Mexican Pesos [US$596.51 million]
of which 64%
was Other), and
(2.96 billion Brazilian Reals [US$932.70 million]
During the year ended December of 2015, sales at
Fleury SA were 1.89 billion Brazilian Reals (US$597.78 million).
increase of 12.9%
versus 2014, when the company's sales were 1.68 billion Brazilian Reals.
This was the fifth consecutive year of sales increases at Fleury SA
(and since 2010, sales have increased a total of 117%).
Sales of Diagnostic Medicine saw an increase
14.1% in 2015, from
1.39 billion Brazilian Reals to 1.59 billion Brazilian Reals.